Cdc25 phosphatases activate cyclin-dependent kinases (Cdks) by dephosphoryl
ating critical phospho-tyrosine and phospho-threonine residues on these pro
teins. Several types of studies indicate that Cdc25s can enhance cell proli
feration and oncogenesis, Furthermore, overexpression of Cdc25A and/or B ha
ve been detected in several types of primary human cancers, including breas
t cancers. To further assess the oncogenic capacity of Cdc25B in vivo, we h
ave generated transgenic mice that overexpress Cdc25B in the mammary epithe
lium, driven by the MMTV-LTR promoter. Although these mice are grossly norm
al for up to 18 months, the ectopic expression of Cdc25B in their mammary g
lands increases the susceptibility of these mice to induction of mammary tu
mors by the carcinogen 9,10-dimethyl-1,2-benzanthracene (DMBA).